Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-12

Clinical Trial Update: A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing a study drug with placebo and haloperidol in patients with schizophrenia; results from the completed study were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Haldol (haloperidol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2011-04-12